Breaks Categories: News

ThursdayJun 17, 2021 1:23 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Continues Optimization of IntegraSyn(TM) to Increase Cannabinoid Yield

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids. The company announced that its continued optimization of IntegraSyn(TM) has increased the cannabinoid yield to a level of 5 g/L, further improving the economics of this proprietary manufacturing approach in advance of large-scale production. “We are very excited by these impressive yield levels that further validates the IntegraSyn manufacturing approach as a commercially viable solution for large-scale, pharmaceutical-grade GMP production of rare cannabinoids,” said Eric A. Adams, president and chief executive officer of InMed. “While we continue to…

Continue Reading

ThursdayJun 17, 2021 12:46 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Set for Inclusion in Russell 2000 Index

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that the company will be added to the Russell 2000(R) Index, effective June 25, 2021, after the close of the U.S. equity markets. CNSP will be added following the annual reconstitution of the Russell stock indexes. According to the announcement, the Russell 2000 Index, which is a subset of the Russell 3000(R) Index, measures the performance of the small-cap segment of the equity market in the United States and includes an estimated 2,000…

Continue Reading

ThursdayJun 17, 2021 12:30 pm

NetworkNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces Shipment of Initial Vape Cartridge Order to Alberta

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, has shipped its first order of vape cartridges to Alberta. The shipment was made through PRXTF’s wholly owned subsidiary, Pure Extracts Manufacturing Corp., which developed the proprietary one-gram, full-spectrum oil (“FSO”) vape cartridge. The cartridges were shipped to Alberta Gaming, Liquor & Cannabis (“AGLC”), the company’s distribution partner in the province. According to the announcement, consumer demand for Pure Extracts’ Pure Pulls branded 510 vape cartridges within the provincial markets is robust. The order consisted…

Continue Reading

ThursdayJun 17, 2021 11:35 am

NetworkNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Expanded East Coast Capacity to Meet Surging Demand

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER),the country’s largest independent alkaline water company, today announced that two of its leading suppliers have expanded their capacity by opening east coast facilities. According to the update, the company’s exclusive arrangements with these manufacturers will alleviate raw material concerns during its east coast expansion. Additionally, to meet anticipated demand, the company intends to add three new strategically located co-packers prior to the end of the third quarter. “As we position ourselves for continued growth, we continue to deploy assets that allow our production to exceed increased demand for Alkaline88(R),” said Ricky Wright,…

Continue Reading

ThursdayJun 17, 2021 10:53 am

NetworkNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Featured in Latest Episode of Bell2Bell Podcast

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a life sciences technology accelerator, was featured in the Bell2Bell Podcast, a part of InvestorBrandNetwork’s (“IBN”) sustained effort to provide specialized content distribution via widespread syndication channels. XPhyto Therapeutics’ CEO and Director Hugh Rogers joined the latest episode to offer an operational update and discuss the company’s achievements and future plans. XPhyto Therapeutics recently secured European approval and launched an effective 25-minute polymerase chain reaction (“PCR”) test for COVID-19 (“Covid-ID Lab”), with an initial focus on the German market and several other initiatives underway. “This is an exciting time for the company.…

Continue Reading

ThursdayJun 17, 2021 10:42 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) CEO Featured Guest in Latest Stock2Me Podcast

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, announced that chairman and CEO Greg McKee was interviewed on the most recent episode of the Stock2Me Podcast. The podcast features a fascinating array of companies and individuals that are actively revolutionizing business practices within their respective markets. In the interview, McKee talked about the objective of TRYP, which is fundamentally to help patients, as well as identifying and bringing new therapies to patients. McKee also discussed the need for innovation in the psychedelics space and Tryp’s upcoming human clinical…

Continue Reading

ThursdayJun 17, 2021 10:33 am

NetworkNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Plans to Join Russell 2000 Index

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system (“CNS”) disorders, will be added to the Russell 2000(R) Index effective Monday, June 28, 2021. The company will be added to the index at the conclusion of the 2021 Russell Indexes annual reconstitution. Investment managers and institutional investors often use the Russell U.S. Indexes, which are part of global index provider FTSE Russell, as a basis for index funds and as benchmarks for active…

Continue Reading

WednesdayJun 16, 2021 11:44 am

NetworkNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Announces Joint Venture with Data Protection, Encryption Solution Provider

AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art radio-frequency semiconductors for satellite and 5G communications networks, defense, space and other commercial applications, is finalizing a strategic investment and joint venture with SN2N LLC (“SN2N”). SN2N develops low-cost, platform-independent data protection and encryption solutions. The agreement will outline the design and manufacture of an unhackable communications channel built around state-of-the art signal amplification secured by intelligence-community-caliber hardware encryption. The announcement noted that the two companies have already completed a proof-of-concept demonstration and are now moving forward on the development of commercial-grade solutions. The anticipated solutions will be based…

Continue Reading

WednesdayJun 16, 2021 11:16 am

NetworkNewsBreaks — Brain Scientific Inc. (BRSF) Announces Acquisition Agreement

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has entered into a definitive merger agreement to acquire Piezo Motion Corp., a leading innovator of high-precision piezoelectric motion technology. According to the announcement, the merger is designed to expand the market reach of both companies along with their ability to deliver innovative technologies to high-growth markets. Both companies have built impressive teams of scientists, engineers and executives with invaluable expertise in developing and commercializing disruptive technologies, and the acquisition will result in a single company with vast machine learning background and astute ability to address demands in the market. Currently, BRSF’s…

Continue Reading

WednesdayJun 16, 2021 11:07 am

NetworkNewsBreaks –Splash Beverage Group Inc. (NYSE American: SBEV) Closes on $15M Public Offering, Uplists to NYSE American

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, announced that it had closed on an underwritten public offering. The offering, which resulted in $15 million for the company before deductions, was comprised of 3,750,000 shares of common stock along with warrants to purchase another 3,750,000 shares of common stock. The price per share is $4; the warrants are also $4 each. The warrants are exercisable at $4.60 per share and will expire five years from issuance. According to the announcement, SBEV also granted the underwriters an option to purchase up to an additional 562,500 shares of…

Continue Reading